Loading [MathJax]/jax/output/SVG/config.js

ZMB Member Alexander Roesch

ZMB Member
Alexander Roesch

Next ZMB-Member
Alexander Roesch portrait
© UKE

Prof. Dr. Alexander Roesch

Clinic for Dermatology
University Hospital Essen
Hufelandstraße 55
45147 Essen

Research Overview

Melanoma is an aggressive tumor with dramatically reduced patient survival when disseminated to distant organs. Despite the historic success of modern cancer drugs, the cure of patients is hampered by the notorious tumor heterogeneity and plasticity of melanoma leading to therapy failure in most cases and limited diagnostic options to monitor therapy response/resistance over time.

Alexander Roesch research image
© Alexander Roesch

Recent work and topics

Alexander Roesch research image
© Alexander Roesch

Tumor cell state switching & Therapy resistance in melanoma
Accumulating evidence indicates that therapy and immune escape in cancer is not solely driven by genetic evolution, but also by the epigenetic adaptive plasticity of cell phenotypes. Current findings by us and others point to an understanding of melanoma as a highly plastic system, in which tumor cell subpopulations dynamically switch between multiple cellular identities (e.g. differentiated vs. de-differentiated, OXPHOS-driven vs. glycolytic, high vs. low ROS detoxifying, etc.) depending on the current therapeutic and microenvironmental context. As initiator and consortial member of the Clinical Research Unit CRU/KFO 337 (PhenoTImE), we are using established and patient-derived cell systems to study and track tumor cell states across different cancer entities in the context of signaling-targeted and immune checkpoint therapies. Technology-wise, our group applies for example cell state-directed fluorescent reporter constructs, multiplexed CODEX™ imaging, mass-spectrometry imaging, mass-spectrometric metabolomics, and, for cell manipulation, CRISPR/Cas9 editing and chemical compound libraries. Alexander Roesch research image
Dynamic therapy and immune escape. While the majority of cancer cells can be eliminated by first-line therapies and immune cell activation, a small portion of the tumor survives (minimal residual disease) and gives rise to clinical tumor relapse. The pre-resistant persister pool (DTP cells, dashed box) comprises a complex reservoir of different cell states from which repopulation of tumor heterogeneity dynamically emerges.
© Alexander Roesch

Regulation of tumor cell fate decisions
The phenotypic capacity to reversibly switch between different cell states provides a fundamental advantage for tumors to survive selective pressure. Our group has focused on the preclinical and clinical description of melanoma persister cell states over the past years. We have shown that melanomas irrespective of their genetic heterogeneity comprise multi-drug resistant, non-proliferating cells that repopulate the tumor and are identified by high expression of the histone H3K4 demethylase KDM5B (JARID1B). However, the exact role of KDM5B for regulating cellular identity and ways to exploit it for biomedical applications are still unclear; especially since the expression of KDM5B does not follow a static hierarchy, but is dynamically changing depending on the therapeutic con-text. Specifically, we hypothesize that KDM5B is a dynamic molecular switch that interconnects cell differentiation and cell cycle control. A deeper understanding of the switches between KDM5B levels and how this triggers transitions in cell states could lead to novel drugs with significant improvement in cancer treatment.

Alexander Roesch research image
Dynamic cell fate decisions. Melanoma cells can dynamically shift between different differentiation, metabolic, and cell cycle states depending on the expression level of KDM5B/JARID1B.
© Alexander Roesch

Liquid biopsy and Tumor monitoring
Personalized oncology has not managed yet to overcome the limitation by inter- and intra-tumor heterogeneity in patients. This dilemma is even further complicated by the limited real-time information that translational research in humans but also in common mouse models can provide due to the high invasiveness of its mostly tissue biopsy-based design. In contrast, liquid biopsies, comprising the noninvasive analysis of circulating tumor-derived material in the blood, represent an innovative tool in precision oncology to overcome current limitations associated with tissue biopsies; however, mostly unspecific markers are used for the sole assessment of tumor load so far, while biology-specific read-outs are not yet implemented. As part of the EU Horizon 2020 Marie Curie Training Program MELGEN and an active member of the European Liquid Biopsy Society (ELBS), we have established a multi-analyte, multi-marker liquid biopsy platform for diagnostic and therapy monitoring application. The goal of our LB projects is to develop a multilateral liquid biopsy platform that allows tumor load monitoring and assessment of tumor biological processes, such as phenotype switching, in melanoma patients and mouse models. Alexander Roesch research image
ctDNA-based serial monitoring for early prediction of therapy outcome. Serial monitoring of mutant ctDNA copies under therapy predicts clinical progression earlier as compared to routine radiologic scans
© Alexander Roesch

Read more

Publications

    Journal articles

  • Keyl, Julius; Keyl, Philipp; Montavon, Grégoire; Hosch, René; Brehmer, Alexander; Mochmann, Liliana; Jurmeister, Philipp; Dernbach, Gabriel; Kim, Moon; Koitka, Sven; Bauer, Sebastian; Bechrakis, Nikolaos; Forsting, Michael; Führer-Sakel, Dagmar; Glas, Mart et al.
    Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
    In: Nature Cancer (2025) in press
  • Placke, Jan-Malte; Rajcsanyi, Luisa Sophie; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Weichenthal, Michael; Meier, Friedegund; Berking, Carola; Leiter, Ulrike; Seier, Johanna; Kref et al.
    Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
    In: Frontiers in Immunology Vol. 16 (2025) 1536642
  • Egea‐Rodriguez, Sara; Váraljai, Renáta; Nordmann, Thierry M.; Lubis, Restuan; Philip, Manuel; Rambow, Florian; Rösch, Alexander; Flaig, Michael; Horn, Susanne; Stoll, Raphael; Zhao, Fang; Paschen, Annette; Klebl, Bert; Hickson, Ian D.; Schadendorf, Dirk; M et al.
    RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma
    In: Clinical and Translational Medicine Vol. 15 (2025) Nr. 1, e70094
  • Albrecht, Jessica Lea; Dimitriou, Florentia; Grover, Piyush; Hassel, Jessica C.; Erdmann, Michael; Forschner, Andrea; Johnson, Douglas B.; Váraljai, Renáta; Lodde, Georg; Placke, Jan-Malte; Krefting, Frederik; Zaremba, Anne; Ugurel, Selma; Rösch, Alexander et al.
    Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
    In: European Journal of Cancer (EJC) Vol. 202 (2024) 113976
  • Chorti, Eleftheria; Kowall, Bernd; Hassel, Jessica C.; Schilling, Bastian; Sachse, Michael; Gutzmer, Ralf; Loquai, Carmen; Kähler, Katharina C.; Hüsing, Anika; Gilde, Catharina; Thielmann, Carl Maximilian; Zaremba-Montenari, Anne; Placke, Jan-Malte; Gratsi et al.
    Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
    In: European Journal of Cancer (EJC) Vol. 200 (2024) 113536
  • Lodde, Georg; Zhao, Fang; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Jansen, Philipp; Kowall, Bernd; Galetzka, et al.
    Early versus late response to PD-1-based immunotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC) Vol. 210 (2024) 114295
  • Tarantino, Giuseppe; Ricker, Cora A.; Wang, Annette; Ge, William; Aprati, Tyler J.; Huang, Amy Y.; Madha, Shariq; Chen, Jiajia; Shi, Yingxiao; Glettig, Marc; Feng, Catherine H.; Frederick, Dennie T.; Freeman, Samuel; Holovatska, Marta M.; Manos, Michael P. et al.
    Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
    In: Science Advances Vol. 10 (2024) Nr. 48, eadp4670
  • Ullrich, Vivien; Ertmer, Sarah; Baginska, Anna; Dorsch, Madeleine; Gull, Hanah H.; Cima, Igor; Berger, Pia; Dobersalske, Celia; Langer, Sarah; Meyer, Loona; Dujardin, Philip; Kebir, Sied; Glas, Martin; Blau, Tobias; Keyvani, Kathy; Rauschenbach, Laurèl; Su et al.
    KDM5B predicts temozolomide-resistant subclones in glioblastoma
    In: iScience Vol. 27 (2024) Nr. 1, 108596
  • Kebir, Sied; Ullrich, Vivien; Berger, Pia; Dobersalske, Celia; Langer, Sarah; Rauschenbach, Laurèl; Trageser, Daniel; Till, Andreas; Lorbeer, Franziska K.; Wieland, Anja; Wilhelm-Buchstab, Timo; Ahmad, Ashar; Fröhlich, Holger; Cima, Igor; Prasad, Shruthi; et al.
    A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
    In: Clinical Cancer Research Vol. 29 (2023) Nr. 2, pp. 488 - 500
  • Lodde, Georg; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Hauschild, Axel; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfa et al.
    Adjuvant treatment and outcome of stage III melanoma patients : Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
    In: European Journal of Cancer (EJC) Vol. 191 (2023) 112957
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; E et al.
    Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer Vol. 4 (2023) Nr. 9, pp. 1395
  • Placke, Jan-Malte; Kimmig, Mona; Griewank, Klaus; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Welzel, Julia; Engel, Daniel Robert; Kre et al.
    Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma ADOREG/TRIM : Analysis of the DeCOG prospective multicenter cohort study
    In: eBioMedicine Vol. 96 (2023) 104774
  • Philip, Manuel; Puppel, Sven Holger; Stiller, Mathias; Paschen, Annette; Rösch, Alexander; Zaremba, Anne; Schadendorf, Dirk; Horn, Susanne.
    Database for queries of melanoma cohorts with molecular and clinical data
    In: Pigment Cell and Melanoma Research Vol. 36 (2023) Nr. 2, pp. 252 - 258
  • Livingstone, Elisabeth; Gogas, H.; Kandolf-Sekulovic, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.A.M.; Gesierich, A.H.; Herbst, R.A.; Kähler, K.C.; Ziogas, D.C.; Mijuskovic, Z.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel, Selma; Gutz et al.
    Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma : The ImmunoCobiVem phase 2 randomised trial
    In: European Journal of Cancer (EJC) Vol. 190 (2023) 112941
  • Stupia, Simone; Heeke, Christina; Brüggemann, Alicia; Zaremba-Montenari, Anne; Thier, Beatrice; Kretz, Julia; Sucker, Antje; Philip, Manuel; Zelinskyy, Gennadiy; Ferrone, Soldano; Rösch, Alexander; Horn, Susanne; Hadaschik, Eva; Schadendorf, Dirk; Trilling et al.
    HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance
    In: Clinical Cancer Research Vol. 29 (2023) Nr. 15, pp. 2894 - 2907
  • Picard, Daniel; Felsberg, Jörg; Langini, Maike; Stachura, Paweł; Qin, Nan; Macas, Jadranka; Reiss, Yvonne; Bartl, Jasmin; Selt, Florian; Sigaud, Romain; Meyer, Frauke-D.; Stefanski, Anja; Stühler, Kai; Roque, Lucia; Roque, Rafael; Pandyra, Aleksandra A.; B et al.
    Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma
    In: Acta Neuropathologica Vol. 149 (2023) Nr. 4, pp. 551 - 564
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; E et al.
    Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer Vol. 4 (2023) Nr. 9, pp. 1292 - 1308
  • Hassel, Jessica C.; Zimmer, Lisa; Sickmann, Thomas; Eigentler, Thomas K.; Meier, Friedegund; Mohr, Peter; Pukrop, Tobias; Rösch, Alexander; Vordermark, Dirk; Wendl, Christina; Gutzmer, Ralf.
    Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition
    In: Cancers Vol. 15 (2023) Nr. 13, 3448
  • Placke, Jan-Malte; Mertens, Delphine; Tasdogan, Alpaslan; Chorti, Eleftheria; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Stoffels, Ingo; Klode, Joachim.
    Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy
    In: Journal of the European Academy of Dermatology and Venereology Vol. 37 (2023) Nr. 5: Special issue on melanoma: Immune check point and BRAF‐MEK inhibitors in melanoma, pp. 907 - 913
  • Placke, Jan-Malte; Zahn, Maximilian; Zillikens, Hannah; Krefting, Frederik; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Sucker, Antje; Roesch, Alexander; Tasdogan, Alpaslan; Srinivas, Nalini K.; Schadendorf, Dirk; Becker, Jürgen C.; et al.
    Prognostic factors in the primary care of patients with Merkel cell carcinoma : A monocentric cohort study of 108 patients from a tertiary referral centre
    In: JEADV Clinical Practice Vol. 2 (2023) Nr. 4, pp. 810 - 818
  • Kehrmann, Jan; Koch, Fiona; Zumdick, Skrollan; Höwner, Anna; Best, Lara; Masshöfer, Lars; Scharfenberg, Sarah; Zeschnigk, Michael; Becker, Jürgen C.; Schadendorf, Dirk; Buer, Jan; Rösch, Alexander.
    Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies
    In: Microbiology Spectrum Vol. 11 (2023) Nr. 3, e04401-22
  • Livingstone, Elisabeth; Zimmer, Lisa; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas K.; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kiecker, Felix; Dip et al.
    Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : Final results of a randomised, double-blind, phase 2 trial
    In: Lancet Vol. 400 (2022) Nr. 10358, pp. 1117 - 1129
  • Liu, Wei; Stachura, Paweł; Xu, Haifeng C.; Váraljai, Renáta; Shinde, Prashant; Ganesh, Nikkitha Umesh; Mack, Matthias; Van Lierop, Anke; Huang, Anfei; Sundaram, Balamurugan; Lang, Karl S.; Picard, Daniel; Fischer, Ute; Remke, Marc; Homey, Bernhard; Rösch, et al.
    BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
    In: Cancer Research Vol. 82 (2022) Nr. 2, pp. 264 - 277
  • Jansen, Philipp; Lodde, Georg; Wetter, Axel; Welt, Anja; Stuschke, Martin; Dührsen, U.; Stoffels, Ingo; Klode, Joachim; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma.
    Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitors
    In: Journal of the European Academy of Dermatology and Venereology Vol. 36 (2022) Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, pp. 41 - 44
  • Albrecht, Lea Jessica; Höwner, Anna; Griewank, Klaus; Lueong, Smiths S.; von Neuhoff, Nils; Horn, Peter; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, Susanne; Siveke, Jens; Schadendorf, Dirk; Váraljai, Renáta; et al.
    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
    In: Clinical and Translational Medicine Vol. 12 (2022) Nr. 11, e1090
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebast et al.
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer Vol. 10 (2022) Nr. 6, e004509
  • Stejerean-Todoran, Ioana; Zimmermann, Katharina; Gibhardt, Christine S; Vultur, Adina; Ickes, Christian; Shannan, Batool; Bonilla del Rio, Zuriñe; Wölling, Anna; Cappello, Sabrina; Sung, Hsu-Min; Shumanska, Magdalena; Zhang, Xin; Nanadikar, Maithily; Latif et al.
    MCU controls melanoma progression through a redox-controlled phenotype switch
    In: EMBO Reports Vol. 23 (2022) Nr. 11, e54746
  • Jansen, Philipp; Lodde, Georg; Griewank, Klaus; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk.
    Management of partial and non-responding cutaneous squamous cell carcinoma
    In: Journal of the European Academy of Dermatology and Venereology Vol. 36 (2022) Nr. S1, pp. 29 - 34
  • Chauvistré, Heike; Shannan, Batool; Daignault-Mill, Sheena M.; Ju, Robert J.; Picard, Daniel; Egetemaier, Stefanie; Váraljai, Renáta; Gibhardt, Christine S.; Sechi, Antonio; Kaschani, Farnusch; Keminer, Oliver; Stehbens, Samantha J.; Liu, Qin; Yin, Xiangfa et al.
    Persister state-directed transitioning and vulnerability in melanoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Nature Communications Vol. 13 (2022) Nr. 1, pp. 35 - 36
  • Placke, Jan-Malte; Rawitzer, Josefine; Reis, Henning; Rashidi-Alavijeh, Jassin; Livingstone, Elisabeth; Ugurel, Selma; Hadaschik, Eva; Griewank, Klaus; Schmid, Kurt Werner; Schadendorf, Dirk; Rösch, Alexander; Zimmer, Lisa.
    Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry
    In: Frontiers in Oncology Vol. 11 (2021) 725549
  • Zaremba, Anne; Philip, Manuel; Hassel, Jessica C.; Glutsch, Valerie; Fiocco, Zeno; Loquai, Carmen; Rafei-Shamsabadi, David; Gutzmer, Ralf; Utikal, Jochen; Haferkamp, Sebastian; Reinhardt, Lydia; Kähler, Katharina C.; Weishaupt, Carsten; Moreira, Alvaro; Th et al.
    Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
    In: European Journal of Cancer (EJC) Vol. 152 (2021) pp. 139 - 154
  • Placke, Jan-Malte; Reis, Henning; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Stoffels, Ingo; Klode, Joachim.
    Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up : A monocentre study
    In: European Journal of Cancer (EJC) Vol. 154 (2021) pp. 167 - 174
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Christiane; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michae et al.
    Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma
    In: Frontiers in Oncology Vol. 11 (2021) 741993
  • Lodde, Georg; Forschner, Andrea; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Schatton, Kerstin; Gebhardt, Christoffer; Eckardt, Julia; Gutzmer, Ral et al.
    Factors influencing the adjuvant therapy decision : Results of a real-world multicenter data analysis of 904 melanoma patients
    In: Cancers Vol. 13 (2021) Nr. 10, pp. 2319
  • Váraljai, Renáta; Horn, Susanne; Sucker, Antje; Pierscianek, Daniela; Schmitt, Verena; Carpinteiro, Alexander; Becker, Katrin; Reifenberger, Julia; Rösch, Alexander; Felsberg, Joerg; Reifenberger, Guido; Sure, Ulrich; Schadendorf, Dirk; Helfrich, Iris.
    Integrative genomic analyses of patient-matched intracranial and extracranial metastases reveal a novel brain-specific landscape of genetic variants in driver genes of malignant melanoma
    In: Cancers Vol. 13 (2021) Nr. 4, pp. 731
  • Chorti, Eleftheria; Kebir, Sied; Ahmed, Misbah S.; Keyvani, Kathy; Umutlu, Lale; Kanaki, Theodora; Zaremba, Anne; Reinboldt-Jockenhöfer, Finja; Knispel, Sarah; Gratsias, Emmanouil; Rösch, Alexander; Ugurel, Selma; Scheffler, Björn; Schadendorf, Dirk; Livin et al.
    Leptomeningeal disease from melanoma : Poor prognosis despite new therapeutic modalities
    In: European Journal of Cancer (EJC) Vol. 148 (2021) pp. 395 - 404
  • Harbers, Franziska Noelle; Thier, Beatrice; Stupia, Simone; Zhu, Si; Schwamborn, Marion; Peller, Vicky; Chauvistré, Heike; Crivello, Pietro; Fleischhauer, Katharina; Rösch, Alexander; Sucker, Antje; Schadendorf, Dirk; Chen, Yong; Paschen, Annette; Zhao, Fa et al.
    Melanoma Differentiation Trajectories Determine Sensitivity Toward Pre-Existing CD8⁺ Tumor-Infiltrating Lymphocytes
    In: Journal of Investigative Dermatology Vol. 141 (2021) Nr. 10, pp. 2480 - 2489
  • Brase, Jan C.; Walter, Robert F.H.; Savchenko, Alexander; Gusenleitner, Daniel; Garrett, James; Schimming, Tobias; Varaljai, Renata; Castelletti, Deborah; Kim, Ju; Dakappagari, Naveen; Schultz, Ken; Robert, Caroline; Long, Georgina V.; Nathan, Paul D.; Rib et al.
    Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
    In: Clinical Cancer Research Vol. 27 (2021) Nr. 16, pp. 4500 - 4510
  • Váraljai, Renáta; Elouali, S.; Lueong, Smiths S.; Wistuba-Hamprecht, Kilian; Seremet, Teofila C.; Siveke, Jens; Becker, Jürgen; Sucker, Antje; Paschen, Annette; Horn, Peter; Neyns, Bart; Weide, Benjamin M.; Schadendorf, Dirk; Rösch, Alexander.
    The predictive and prognostic significance of cell-free DNA concentration in melanoma
    In: Journal of the European Academy of Dermatology and Venereology Vol. 35 (2021) Nr. 2, pp. 387 - 395
  • Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, et al.
    Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : A randomised, double-blind, placebo-controlled, phase 2 trial
    In: Lancet Vol. 395 (2020) Nr. 10236, pp. 1558 - 1568
  • Chorti, Eleftheria; Kanaki, Theodora; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Gratsias, Emmanouil; Rösch, Alexander; Bonella, Francesco; Wessendorf, Thomas; Wälscher, Julia; Theegarten, Dirk; Schadendorf, Dirk; Livingstone, Elisabeth.
    Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy : Increased rate and mimicker of metastasis
    In: European Journal of Cancer (EJC) Vol. 131 (2020) pp. 18 - 26
  • Koch, F.; Salva, Katrin Agnes; Wirtz, M.; Hadaschik, Eva; Varaljai, Renáta; Schadendorf, Dirk; Rösch, Alexander.
    Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses : A prospective, randomized and rater-blinded study (ACTICAP)
    In: Journal of the European Academy of Dermatology and Venereology Vol. 34 (2020) Nr. 12, pp. E844 - E846
  • Zaremba, Anne; Zimmer, Lisa; Chorti, Eleftheria; Reissig, Timm M.; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Hadaschik, Eva; Griewank, Klaus; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth.
    Fatal swelling of the groin – Clear cell sarcoma : A rare but important differential diagnosis to malignant melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Vol. 18 (2020) Nr. 10, pp. 1165 - 1168
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth.
    Immuntherapie beim malignen Melanom
    In: Der Internist Vol. 61 (2020) Nr. 7, pp. 669 - 675
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth.
    Malignes Melanom : Stellenwert der BRAF-Inhibition beim malignen Melanom
    In: Der Onkologe Vol. 26 (2020) Nr. 8, pp. 713 - 720
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker et al.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers Vol. 12 (2020) Nr. 2, pp. 353
  • Eigentler, Thomas K.; Augustin, Matthias; Beer, Ambros J.; Bendel, Martin; Berking, Carola; Bölükbas, Servet; Dippel, Egdar; Fehm, Tanja; Feyer, Petra; Foilman, Markus; Forschner, Andrea; Frerich, Bernhard; Gärtner, Jan; Gutzmer, Ralf; Haferkamp, Sebastian et al.
    S3 Guideline for the Diagnosis, Therapy and Follow‐Up of Malignant Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Vol. 18 (2020) Nr. 10, pp. 1079 - 1208
  • Krahn, Daniel; Heilmann, Geronimo; Vogel, Felix C. E.; Papadopoulos, Chrisovalantis; Zweerink, Susanne; Kaschani, Farnusch; Meyer, Hemmo; Rösch, Alexander; Kaiser, Markus.
    Zelkovamycin is an OXPHOS Inhibitory Member of the Argyrin Natural Product Family
    In: Chemistry - A European Journal Vol. 26 (2020) Nr. 39, pp. 8524 - 8531
  • Váraljai, Renáta; Wistuba-Hamprecht, Kilian; Seremet, Teofila; Diaz, Joey Mark S.; Nsengimana, Jérémie; Sucker, Antje; Griewank, Klaus; Placke, Jan-Malte; Horn, Peter A.; Neuhoff, Nils von; Shannan, Batool; Chauvistré, Heike; Vogel, Felix C.E.; Horn, Susan et al.
    Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma
    In: JCO Precision Oncology Vol. 3 (2019)
  • Zaremba, Anne; Murali, Rajmohan; Jansen, Philipp; Möller, Inga; Sucker, Antje; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Brinker, Titus J.; Hadaschik, Eva; Franklin, Cindy; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus; et al.
    Clinical and genetic analysis of melanomas arising in acral sites
    In: European Journal of Cancer (EJC) Vol. 119 (2019) pp. 66 - 76
  • Zaremba, Anne; Chorti, Eleftheria; Jockenhöfer, Finja; Bolz, Saskia; Sirin, Selma; Glas, Martin; Becker, Jürgen C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Hagenacker, Tim; Zimmer, Lisa.
    Metastatic Merkel cell carcinoma and myasthenia gravis : contraindication for therapy with immune checkpoint inhibitors?
    In: Journal for ImmunoTherapy of Cancer Vol. 7 (2019) Nr. 1, pp. 141
  • Shannan, B.; Matschke, Johann; Chauvistré, Heike; Vogel, F.; Klein, Diana; Meier, Friedegund; Westphal, Dana; Bruns, Johannes; Rauschenberg, Ricarda; Utikal, Jochen; Forschner, Andrea; Berking, Carola; Terheyden, Patrick; Dabrowski, Evelyn; Gutzmer, Ralf; et al.
    Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV⁶⁰⁰E inhibition in melanoma
    In: European Journal of Cancer (EJC) Vol. 109 (2019) pp. 137 - 153
  • Vogel, Felix C. E.; Bordag, Natalie; Zügner, E.; Trajkovic-Arsic, Marija; Chauvistré, Heike; Shannan, Batool; Váraljai, Renáta; Horn, Susanne; Magnes, Christoph; Siveke, Jens; Schadendorf, Dirk; Rösch, Alexander.
    Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells
    In: Journal of Investigative Dermatology Vol. 139 (2019) Nr. 12, pp. 2506 - 2516.e10
  • Varaljai, R.; Wistuba-Hamprecht, K.; Seremet, T.; Diaz, JMS; Nsengimana, J.; Sucker, A.; Griewank, Klaus; Horn, Peter; von Neuhoff, N.; Shannan, B.; Chauvistre, H.; Vogel, FCE; Horn, S.; Becker, J. C.; Newton-Bishop, J.; Stang, Andreas; Neyns, B.; Weide, B et al.
    ctDNA as a noninvasive monitoring tool in metastatic melanoma
    In: Journal of Clinical Oncology (JCO) Vol. 37 (2019) Nr. Suppl. 15, pp. 9548
  • Wirtz, M.; Stoffels, Ingo; Dissemond, Joachim; Schadendorf, Dirk; Rösch, Alexander.
    Actinic keratoses treated with cold atmospheric plasma
    In: Journal of the European Academy of Dermatology and Venereology Vol. 32 (2018) Nr. 1, pp. e37 - e39
  • Schadendorf, Dirk; Van Akkooi, Alexander; Berking, Carola; Griewank, Klaus; Gutzmer, Ralf; Hauschild, Axel; Stang, Andreas; Rösch, Alexander; Ugurel, Selma.
    Melanoma
    In: Lancet Vol. 392 (2018) Nr. 10151, pp. 971 - 984
  • Kunz, Manfred; Löffler-Wirth, Henry; Dannemann, Michael; Willscher, Edith; Doose, Gero; Kelso, Janet; Kottek, Tina; Nickel, Birgit; Hopp, Lydia; Landsberg, Jenny; Hoffmann, Steve; Tüting, Thomas; Zigrino, Paola; Mauch, Cornelia; Utikal, Jochen; Ziemer, Mir et al.
    RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas
    In: Oncogene Vol. 37 (2018) Nr. 47, pp. 6136 - 6151
  • Jockenhöfer, Finja; Schimming, Tobias T.; Schaller, Jörg; Moege, Jürgen; Livingstone, Elisabeth; Salva, Katrin A.; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander.
    Sebaceous tumours: more than skin deep
    In: Gut Vol. 67 (2018) Nr. 11, pp. 2045 - 2053
  • Krepler, Clemens; Sproesser, Katrin; Brafford, Patricia; Beqiri, Marilda; Garman, Bradley; Xiao, Min; Shannan, Batool; Watters, Andrea; Perego, Michela; Zhang, Gao; Vultur, Adina; Yin, Xiangfan; Liu, Qin; Anastopoulos, Ioannis N.; Wubbenhorst, Bradley; Wil et al.
    A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
    In: Cell Reports Vol. 21 (2017) Nr. 7, pp. 1953 - 1967
  • Ugurel, Selma; Kiecker, Felix; Fröhling, Stefan; Wetter, Axel; Bankfalvi, Agnes; Sucker, Antje; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Becker, Jürgen; Schadendorf, Dirk.
    Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC) Vol. 83 (2017) pp. 142 - 145
  • Franklin, Cindy; Livingstone, Elisabeth; Rösch, Alexander; Schilling, Bastian; Schadendorf, Dirk.
    Immunotherapy in melanoma : Recent advances and future directions
    In: European Journal of Surgical Oncology Vol. 43 (2017) Nr. 3, pp. 604 - 611
  • Behera, Reeti; Kaur, Amanpreet; Webster, Marie R.; Kim, Suyeon; Ndoye, Abibatou; Kugel, Curtis H.; Alicea, Gretchen M.; Wang, Joshua; Ghosh, Kanad; Cheng, Phil; Lisanti, Sofia; Marchbank, Katie; Dang, Vanessa; Levesque, Mitchell; Dummer, Reinhard; Xu, Xiao et al.
    Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of klotho
    In: Clinical Cancer Research Vol. 23 (2017) Nr. 12, pp. 3181 - 3190
  • Brinker, Titus Josef; Schadendorf, Dirk; Klode, Joachim; Cosgarea, Ioana; Rösch, Alexander; Jansen, Philipp; Stoffels, Ingo; Izar, Benjamin.
    Photoaging Mobile Apps as a Novel Opportunity for Melanoma Prevention: Pilot Study.
    In: JMIR mhealth and uhealth Vol. 5 (2017) Nr. 7, e101
  • Heppt, Markus V.; Rösch, Alexander; Weide, Benjamin; Gutzmer, Ralf; Meier, Friedegund; Loquai, Carmen; Kähler, Katharina C.; Gesierich, Anja; Meissner, Markus; Bubnoff, Dagmar von; Göppner, Daniela; Schlaak, Max; Pföhler, Claudia; Utikal, Jochen; Heinzerli et al.
    Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma
    In: European Journal of Cancer (EJC) Vol. 81 (2017) pp. 36 - 44
  • Cosgarea, Ioana; Ugurel, Selma; Sucker, Antje; Livingstone, Elisabeth; Zimmer, Lisa; Ziemer, Mirjana; Utikal, Jochen; Mohr, Peter; Pfeiffer, Christiane; Pföhler, Claudia; Hillen, Uwe; Horn, Susanne; Schadendorf, Dirk; Griewank, Klaus; Rösch, Alexander.
    Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
    In: OncoTarget Vol. 8 (2017) Nr. 25, pp. 40683 - 40692
  • Jockenhöfer, Finja; Gollnick, Harald; Herberger, Katharina; Isbary, Georg; Renner, Regina; Stücker, Markus; Valesky, Eva; Wollina, Uwe; Weichenthal, Michael; Karrer, Sigrid; Kuepper, Bernhard; Rösch, Alexander; Dissemond, Joachim.
    Aetiology, comorbidities and cofactors of chronic leg ulcers : retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany
    In: International Wound Journal (IWJ) Vol. 13 (2016) Nr. 5, pp. 821 - 828
  • Graf, Saskia Anna; Rösch, Alexander.
    Arbeitsgemeinschaft Dermatologische Onkologie (ADO) : Bericht über den 3. ADO Nachwuchs-Retreat
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Vol. 14 (2016) Nr. 2, pp. 213 - 214
  • Herz, Saskia; Höfer, Thomas; Papapanagiotou, Matina; Leyh, Julia Christina; Meyenburg, Sarah; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Livingstone, Elisabeth; Schilling, Bastian; Franklin, Cindy.
    Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient
    In: European Journal of Cancer (EJC) Vol. 67 (2016) pp. 66 - 72
  • Sondermann, Wiebke; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander; Klode, Joachim; Dissemond, Joachim.
    Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis
    In: Medicine Vol. 95 (2016) Nr. 29, pp. e4332
  • Facompre, Nicole D; Harmeyer, Kayla M; Sole, Xavier; Kabraji, Sheheryar; Belden, Zachary; Sahu, Varun; Whelan, Kelly; Tanaka, Koji; Weinstein, Gregory S; Montone, Kathleen T; Rösch, Alexander; Gimotty, Phyllis A; Herlyn, Meenhard; Rustgi, Anil K; Nakagawa, et al.
    JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers
    In: Cancer Research Vol. 76 (2016) Nr. 18, pp. 5538 - 5549
  • Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Schilling, Bastian.
    Medikamentöse Therapie des metastasierten malignen Melanoms
    In: Arzneimitteltherapie (AMT) Vol. 34 (2016) Nr. 1-2, pp. 14 - 22
  • Zhao, Fang; Sucker, Antje; Horn, Susanne; Heeke, Christina; Bielefeld, Nicola; Schrörs, Barbara; Bicker, Anne; Lindemann, Monika; Rösch, Alexander; Gaudernack, Gustav; Stiller, Mathias; Becker, Jürgen; Lennerz, Volker; Wölfel, Thomas; Schadendorf, Dirk; Gr et al.
    Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
    In: Cancer Research Vol. 76 (2016) Nr. 15, pp. 4347 - 4358
  • Jockenhöfer, Finja; Klode, Joachim; Kröger, Knut; Rösch, Alexander; Al Ghazal, Philipp; Dissemond, Joachim.
    Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012
    In: International Wound Journal (IWJ) Vol. 13 (2016) Nr. 5, pp. 951 - 956
  • Rösch, Alexander; Paschen, Annette; Landsberg, Jenny; Helfrich, Iris; Becker, Jürgen; Schadendorf, Dirk.
    Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
    In: European Journal of Cancer (EJC) Vol. 59 (2016) pp. 109 - 112
  • Rompoti, Natalia; Hillen, Uwe; Rösch, Alexander; Dissemond, Joachim.
    Purpura fulminans related to paroxysmal nocturnal haemoglobinuria
    In: European Journal of Dermatology (EJD) Vol. 26 (2016) Nr. 4, pp. 397 - 398
  • Stanisz, Hedwig; Bogeski, Ivan; Rösch, Alexander; Herlyn, Meenhard; Vultur, Adina.
    The role of Orai–STIM calcium channels in melanocytes and melanoma
    In: Journal of Physiology Vol. 594 (2016) Nr. 11, pp. 2825 - 2835
  • Livingstone, Elisabeth; Swann, Suzanne; Lilla, Carmen; Schadendorf, Dirk; Rösch, Alexander.
    Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma
    In: Experimental Dermatology Vol. 24 (2015) Nr. 9, pp. 709 - 710
  • Stoffels, Ingo; Morscher, S.; Helfrich, Iris; Hillen, Uwe; Lehy, J.; Burton, N. C.; Poppel, T.; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Gunzer, Matthias; Klode, Joachim.
    Die multispektraloptoakustische Tomographie (MSOT) zur nichtinvasiven Diagnostik des Schildwächterlymphknotens bei Patienten mit malignem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Vol. 13 (2015) Nr. 12, pp. 1323
  • Schadendorf, Dirk; Fisher, David E; Garbe, Claus; Gershenwald, Jeffrey E; Grob, Jean-Jacques; Halpern, Allan; Herlyn, Meenhard; Marchetti, Michael A; McArthur, Grant; Ribas, Antoni; Rösch, Alexander; Hauschild, Axel.
    Melanoma
    In: Nature Reviews Disease Primers Vol. 1 (2015) pp. 15003
  • Stoffels, Ingo; Morscher, Stefan; Helfrich, Iris; Hillen, Uwe; Leyh, Julia; Burton, Neal C.; Sardella, Thomas C.P.; Claussen, Jing; Pöppel, Thorsten; Bachmann, Hagen Sjard; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Gunzer, Matthias; Klode, Joac et al.
    Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging
    In: Immunotherapy Vol. 7 (2015) Nr. 317, pp. 317ra199
  • Cierlitza, Monika; Chauvistré, Heike; Bogeski, Ivan; Zhang, Xin; Hauschild, Axel; Herlyn, Meenhard; Schadendorf, Dirk; Vogt, Thomas; Rösch, Alexander.
    Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations
    In: Experimental Dermatology Vol. 24 (2015) Nr. 2, pp. 155 - 157
  • Schadendorf, Dirk; Livingstone, Elisabeth; Schilling, Bastian; Rösch, Alexander; Zimmer, Lisa.
    Therapie des malignen Melanoms
    In: Der Onkologe Vol. 21 (2015) Nr. 10, pp. 965 - 974
  • Rösch, Alexander.
    Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
    In: Oncogene Vol. 34 (2015) Nr. 23, pp. 2951 - 2957
  • Rösch, Alexander.
    Tumorstammzellen im Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Vol. 13 (2015) Nr. 2, pp. 118 - 124
  • Rösch, Alexander.
    'TWIST and switch' metastasis
    In: Pigment Cell and Melanoma Research Vol. 27 (2014) Nr. 2, pp. 157 - 158
  • Rösch, Alexander; Weber, Christiane.
    Arbeitsgemeinschaft Dermatologische Onkologie (ADO)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Vol. 12 (2014) Nr. 1, pp. 96 - 97
  • Jockenhöfer, Finja; Chapot, le Saout, Valerie; Stoffels-Weindorf, Maren; Körber, Andreas; Klode, Joachim; Buer, Jan; Küpper, Bernhard; Rösch, Alexander; Dissemond, Joachim.
    Bacterial spectrum colonizing chronic leg ulcers : a 10-year comparison from a German wound care center
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Vol. 12 (2014) Nr. 12, pp. 1121 - 1127
  • Stanisz, Hedwig; Saul, Stephanie; Müller, Cornelia S.L.; Kappl, Reinhard; Niemeyer, Barbara A.; Vogt, Thomas; Hoth, Markus; Rösch, Alexander; Bogeski, Ivan.
    Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry
    In: Pigment Cell and Melanoma Research Vol. 27 (2014) Nr. 3, pp. 442 - 453
  • Wang, Tao; Ge, Yingbin; Xiao, Min; Lopez-Coral, Alfonso; Li, Ling; Rösch, Alexander; Huang, Catherine; Alexander, Peter; Vogt, Thomas; Xu, Xiaowei; Hwang, Wei-Ting; Lieu, Melissa; Belser, Eric; Liu, Rui; Somasundaram, Rajasekharan; Herlyn, Meenhard; Kaufma et al.
    SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway
    In: Journal of Investigative Dermatology Vol. 134 (2014) Nr. 4, pp. 1108 - 1118
  • Niessner, Heike; Forschner, Andrea; Klumpp, Bernhard; Honegger, Jürgen B; Witte, Maria; Bornemann, Antje; Dummer, Reinhard; Adam, Annemarie; Bauer, Jürgen; Tabatabai, Ghazaleh; Flaherty, Keith; Sinnberg, Tobias; Beck, Daniela; Leiter, Ulrike; Mauch, Cornel et al.
    Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
    In: Cancer Medicine Vol. 2 (2013) Nr. 1, pp. 76 - 85